PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.
CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises
Alfacell Corporation Announces Closing of $3.25 Million Private Placement
To keep up to date with news from this category use our
Veeco Completes Common Stock Offering
PLAINVIEW, N.Y.--Nov. 3, 2009-- Veeco Instruments Inc. (Nasdaq: VECO) announced today that it has closed its recent public offering of common stock. Veeco sold 5,750,000 shares of common stock (including 750,000 shares...
Oncolytics Biotech
CALGARY, AB - November 3, 2009 - Oncolytics Biotech Inc. ("Oncolytics" or the "Corporation") (TSX:ONC; NASDAQ:ONCY) announces, that pursuant to the accelerated expiry of those warrants issued on May 13, 2009, the...
ART Secures up to $1.2 Million in Interim Financing in Connection with the Pursuit of its Strategic Review Process and Files a Notice of Intention Under the Bankruptcy and Insolvency Act
Montreal, Canada, November 2, 2009 - ART Advanced Research Technologies Inc. (ART) (TSX: ARA), a Canadian medical device company and a leader in optical molecular imaging products for the healthcare and pharmaceutical...
PDL BioPharma Announces Closing of $300,000,000 Securitization Transaction
INCLINE VILLAGE, Nev., Nov. 2, 2009 -- PDL BioPharma, Inc. (PDL) (Nasdaq: PDLI) today announced that it closed on its previously disclosed $300 million securitization transaction intended to monetize certain of its...
Varian Medical Systems Selected to Supply Major Project to Bring Advanced Radiotherapy Treatments to North of Portugal Cancer Patients to Benefit from State-of-the-Art RapidArc and Novalis Tx Installations
PORTO, Portugal, Oct. 30, 2009-- Cancer patients in northern Portugal will gain access to advanced cancer treatments with the acquisition of seven new treatments machines from Varian Medical Systems (NYSE: VAR) by the...
CEL-SCI Corporation Strengthens Balance Sheet Through Receipt of $10 Million From Warrant Exercises
VIENNA, Va., Oct. 26 -- CEL-SCI Corporation (NYSE Amex: CVM) announced today that it has received over $10 million over the past 60 days through the exercise of warrants by investors to purchase the Company's common...
St. Jude Medical Board of Directors Authorizes Share Repurchase
ST. PAUL, Minn.----Oct. 23, 2009-- St. Jude Medical, Inc. (NYSE:STJ) announced today that its Board of Directors has authorized a share repurchase of up to $500 million of its outstanding common stock. The repurchases...
PhotoMedex Raises $2.7 Million in Private Placement of Common Stock
MONTGOMERYVILLE, Pa.----Oct. 23, 2009-- PhotoMedex, Inc. (Nasdaq:PHMD) today announced that it has closed a private placement of approximately 4.17 million shares of its common stock at a price of $0.65 per share. Gross...
COLUMBIA LABORATORIES ANNOUNCES REGISTERED DIRECT COMMON STOCK OFFERING
LIVINGSTON, NJ -- October 23, 2009 -- Columbia Laboratories, Inc. (Nasdaq: CBRX) today announced that it has priced a transaction to raise up to approximately $11,772,000 through the sale of up to approximately...
Ad hoc announcement in accordance with
Planegg-Martinsried, Germany, October 23, 2009 - 4SC AG (Frankfurt, Prime Standard: VSC) the drug discovery and development company, today announced that its Management Board, with the approval of the Supervisory Board,...
API successfully completes the institutional component of its $150m equity raising
October 23, 2009 - Australian Pharmaceutical Industries (ASX: API), a leading Australian healthcare company and one of Australia's leading health and beauty retailers, today announced the successful completion of its...
Inhibitex Announces Equity Financing of $23 Million
ATLANTA-- October 23, 2009-- Inhibitex, Inc. (Nasdaq: INHX) today announced that it has entered into definitive purchase agreements with institutional investors for the sale of approximately $23 million of its common...
PharmaGap Announces Completion of Securities Lending Arrangements with Stormont.
Ottawa, Ontario/October 21, 2009 - PharmaGap Inc. (TSX-V: GAP; OTC.BB: PHRGF) ("PharmaGap" or "the Company") today advises that the Securities Lending Agreements ("SLA") between SC Stormont Holdings Inc. ("Stormont")...
AGA Medical Holdings, Inc. Announces Pricing of its Initial Public Offering
MINNEAPOLIS, Oct. 21, 2009 -- AGA Medical Holdings, Inc. (the "Company") announced the pricing of its initial public offering of 13,750,000 shares of common stock at $14.50 per share. The Company expects to sell...
Alfacell Corporation Announces Closing of $3.25 Million Private Placement
SOMERSET, N.J., Oct. 20, 2009 -- Alfacell Corporation (Pink Sheets:ACEL) today announced that it has closed a private placement with certain investors in which it raised $3.25 million in gross proceeds through the sale...
iCo Therapeutics Announces $4,000,000 Brokered Private Placement
October 20, 2009 -- VANCOUVER, Canada-- iCo Therapeutics Inc. (TSX-V: ICO) ("iCo" or the "Company") is pleased to announce that Loewen, Ondaatje, McCutcheon Limited and Versant Partners Inc. (collectively, the "Agents")...
MedaSorb Technologies Corporation Raises $1.3M in Series B Warrant Exercise
MONMOUTH JUNCTION, NJ-- 10/09/09 - MedaSorb Technologies Corporation (OTC.BB:MSBT - News) and its wholly-owned subsidiary CytoSorbents, Inc., announced that it has raised $1.3 million in the exercise of the warrant...
Sernova Corp. Announces Private Placement - Company To Present At Biocontact Conference In Quebec City
London, Ontario - October 7th, 2009 - Sernova Corp. (TSX-V: SVA) today announced that it is undertaking a non-brokered private placement offering of up to 6.6 million Units at a price of $0.15 per Unit for gross...
Inviragen, Inc. subscribes to R&D Time software and services
6 October 2009 -- Inviragen and SingVax have merged their complementary vaccine pipelines and their international product development capabilities to create a company that is developing a wide range of vaccines for...
Alexza to Raise $19.7 Million in Private Placement
MOUNTAIN VIEW, Calif., Sept. 30 -- Alexza Pharmaceuticals, Inc. (Nasdaq: ALXA) announced today that it has entered into a definitive agreement with various institutional investors to raise $19.7 million in a private...
iBio Completes $3 Million Private Placement
NEWARK, DE - September 10, 2009 - iBio, Inc. (OTCBB: IBPM) today announced a private placement of approximately $3 million of its common stock principally to current stockholders who previously purchased the Company's...
Clavis Pharma announces Successful Completion of Share Offering
Oslo, Norway, 18 August 2009--Clavis Pharma ASA (OSE:CLAVIS) today announced the successful completion of the subsequent share offering, following the private placement in June that raised NOK 129 million in gross...
© Copyright 1995-2009 Pharmalicensing, a division of UTEK Europe Ltd 
All rights reserved. Terms and Conditions | Contact us
